-The Economic Times   Govt. to set up National Environment Appraisal and Monitoring Authority for environmental clearance of projects Prime MinisterManmohan Singh hit the nail on the head when he declared that the environment cannot be protected by perpetuating poverty. But the regulatory FRAmework forenvironmental clearance of development projects needs urgent streamlining and reform . Dr Singh added that the Centre would soon set up an independent regulatory body, the National Environment...

It’s been raining “rights” in Indian policy for the last few years — education, work, food, service, healthcare, and much else. This “Diet Coke” approach to poverty reduction — the sweetness without the calories — was always dangerous because of unknown side effects. Commenting in 1790 on the consequences of the French Revolution, Edmund Burke said: “They have found their punishment in their success. Laws overturned, tribunals subverted, industry without...

-The Indian Express   Great expectations are pinned to the upcoming monsoon session of Parliament, given the sheer volume of unfinished legislative business, and the amazing free fall of the past few months. The opposition’s passive-aggressive behaviour and the government’s reflexive obduracy over a JPC were the reason the winter session had to be written off, and that certainly contributed to the clear authority vacuum of recent months, even as agitations...

Homebuyers in Noida can breathe easy. In an important breakthrough, the city's villages have decided to call off their recent agitation over land acquisition-related issues. After arriving at a settlement with Noida Authority on Saturday, the farmers promised not to disrupt work at any of the project sites. However, the agreement does not affect the fate of projects in Noida Extension, where negotiations are still on between farmers and Greater...

Last month, the Archives of Internal Medicine published a scathing reassessment of a 12-year-old research study of Neurontin, a seizure drug made byPfizer. The study, which had included more than 2,700 subjects and was carried out by Parke-Davis (now part of Pfizer), was notable for how poorly it was conducted. The investigators were inexperienced and untrained, and the design of the study was so flawed it generated few if any...